Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2021

May 6, 2021

284_dirs_2021-05-06_fdcf3f91-1075-48fb-9273-bfcb1615e8d1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-05-04

Reporting Person: Karachun Rita A (Sr. VP Fince-Global Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-04 Common Stock M 1212 $75.98 Acquired 36214.972 Direct
2021-05-04 Common Stock F 416 $75.98 Disposed 35798.972 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-04 Stock Option (Right to Buy) $75.99 A 21429 Acquired 2031-05-03 Common Stock (21429) Direct
2021-05-04 Restricted Stock Unit $ A 2764 Acquired 2024-05-04 Common Stock (2764) Direct
2021-05-04 Restricted Stock Unit $ M 1212 Disposed 2021-05-04 Common Stock (1212) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

F5: These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.